Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1524
mi
from 91732
Rochester, MN
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1484
mi
from 91732
Saint Cloud, MN
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Coborn Cancer Center at Saint Cloud Hospital
1484
mi
from 91732
Saint Cloud, MN
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1483
mi
from 91732
Saint Cloud, MN
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Saint Cloud Hospital
1483
mi
from 91732
Saint Cloud, MN
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1340
mi
from 91732
Kansas City, MO
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Saint Luke's Hospital, Kansas City
1340
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1342
mi
from 91732
Kansas City, MO
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
North Kansas City Hospital
1342
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1342
mi
from 91732
Kansas City, MO
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Heartland Hematology Oncology Associates, Incorporated
1342
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1341
mi
from 91732
Kansas City, MO
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Research Medical Center
1341
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1353
mi
from 91732
Lee's Summit, MO
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Saint Luke's East - Lee's Summit
1353
mi
from 91732
Lee's Summit, MO
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1333
mi
from 91732
Saint Joseph, MO
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Saint Joseph Oncology, Inc.
1333
mi
from 91732
Saint Joseph, MO
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
991
mi
from 91732
Great Falls, MT
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Benefis Healthcare- Sletten Cancer Institute
991
mi
from 91732
Great Falls, MT
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1258
mi
from 91732
Lincoln, NE
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Nebraska Cancer Research Center
1258
mi
from 91732
Lincoln, NE
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1300
mi
from 91732
Omaha, NE
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Missouri Valley Cancer Consortium
1300
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1297
mi
from 91732
Omaha, NE
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Alegent Health Immanuel Medical Center
1297
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1294
mi
from 91732
Omaha, NE
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Alegent Health Bergan Mercy Medical Center
1294
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1300
mi
from 91732
Omaha, NE
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Alegent Health Lakeside Hospital
1300
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1299
mi
from 91732
Omaha, NE
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Creighton University Medical Center
1299
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2378
mi
from 91732
Camden, NJ
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Cooper Hospital University Medical Center
2378
mi
from 91732
Camden, NJ
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2445
mi
from 91732
Glens Falls, NY
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Glens Falls Hospital
2445
mi
from 91732
Glens Falls, NY
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2153
mi
from 91732
Asheboro, NC
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Randolph Hospital
2153
mi
from 91732
Asheboro, NC
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2258
mi
from 91732
Goldsboro, NC
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Wayne Memorial Hospital
2258
mi
from 91732
Goldsboro, NC
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2151
mi
from 91732
Greensboro, NC
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Cone Health Cancer Center
2151
mi
from 91732
Greensboro, NC
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2010
mi
from 91732
Hendersonville, NC
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Margaret R Pardee Memorial Hospital
2010
mi
from 91732
Hendersonville, NC
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2156
mi
from 91732
Reidsville, NC
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Annie Penn Memorial Hospital
2156
mi
from 91732
Reidsville, NC
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1257
mi
from 91732
Bismarck, ND
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Sanford Bismarck Medical Center
1257
mi
from 91732
Bismarck, ND
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1444
mi
from 91732
Grand Forks, ND
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Altru Cancer Center
1444
mi
from 91732
Grand Forks, ND
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Bowling Green, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Toledo Clinic Cancer Centers-Bowling Green
mi
from 91732
Bowling Green, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1962
mi
from 91732
Chillicothe, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Adena Regional Medical Center
1962
mi
from 91732
Chillicothe, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1959
mi
from 91732
Columbus, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Riverside Methodist Hospital
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1960
mi
from 91732
Columbus, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Columbus NCI Community Oncology Research Program
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1960
mi
from 91732
Columbus, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Grant Medical Center
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1958
mi
from 91732
Columbus, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Mount Carmel Health Center West
1958
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1960
mi
from 91732
Columbus, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Doctors Hospital
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1896
mi
from 91732
Dayton, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Grandview Hospital
1896
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1897
mi
from 91732
Dayton, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Good Samaritan Hospital - Dayton
1897
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1897
mi
from 91732
Dayton, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Miami Valley Hospital
1897
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1897
mi
from 91732
Dayton, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Samaritan North Health Center
1897
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1900
mi
from 91732
Dayton, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Dayton NCI Community Oncology Research Program
1900
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1957
mi
from 91732
Delaware, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Grady Memorial Hospital
1957
mi
from 91732
Delaware, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2010
mi
from 91732
Elyria, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Hematology Oncology Center Incorporated
2010
mi
from 91732
Elyria, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2010
mi
from 91732
Elyria, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Mercy Cancer Center-Elyria
2010
mi
from 91732
Elyria, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1929
mi
from 91732
Findlay, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Blanchard Valley Hospital
1929
mi
from 91732
Findlay, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1890
mi
from 91732
Franklin, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Atrium Medical Center - Middletown Regional Hospital
1890
mi
from 91732
Franklin, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1874
mi
from 91732
Greenville, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Wayne Hospital
1874
mi
from 91732
Greenville, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1899
mi
from 91732
Kettering, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Kettering Medical Center
1899
mi
from 91732
Kettering, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1981
mi
from 91732
Lancaster, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Fairfield Medical Center
1981
mi
from 91732
Lancaster, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1905
mi
from 91732
Lima, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Lima Memorial Hospital
1905
mi
from 91732
Lima, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2042
mi
from 91732
Marietta, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Marietta Memorial Hospital
2042
mi
from 91732
Marietta, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1931
mi
from 91732
Maumee, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Toledo Clinic Cancer Centers-Maumee
1931
mi
from 91732
Maumee, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1931
mi
from 91732
Maumee, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
1931
mi
from 91732
Maumee, OH
Click here to add this to my saved trials
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1988
mi
from 91732
Mount Vernon, OH
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Phase I/II Trial of IMC-A12 in Combination With Temsirolimus in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Knox Community Hospital
1988
mi
from 91732
Mount Vernon, OH
Click here to add this to my saved trials